OcellO - Ownership and Business Overview

Life ScienceCompany

OcellO Ownership

Who owns OcellO?

OcellO is owned by Crown Bioscience. It was acquired on May 5, 2021.

OcellO Business Overview

Where is OcellO headquartered?

OcellO is headquartered in Leiden, Netherlands.

What sector is OcellO in?

OcellO is a life science company.

When was OcellO founded?

OcellO was founded in 2011.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 388 acquisitions of life science companies in 2021, including 44 acquisitions by private equity firms, and 344 by strategics.

OcellO

OcellO B.V.

J.H. Oortweg 21,
Leiden, 2333 CH
Netherlands,
+31 (0)71 3322 875
www.ocello.nl

OcellO is a provider of compound testing services using advanced organotypic human tissue models of cancer, inflammation, and polycystic kidney disease. Automated 3D cell culture technology is combined with high content 3D imaging and analysis in a robust platform that provides scalability without compromising biological complexity. OcellO was founded in 2011 and is based in Leiden, Netherlands.


 Subscribe to unlock this and 202,005
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.